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We describe here the complete genome sequence of a common
clone of Mycobacterium avium subspecies paratuberculosis (Map)
strain K-10, the causative agent of Johne’s disease in cattle and
other ruminants. The K-10 genome is a single circular chromosome
of 4,829,781 base pairs and encodes 4,350 predicted ORFs, 45
tRNAs, and one rRNA operon. In silico analysis identified >3,000
genes with homologs to the human pathogen, M. tuberculosis
(Mtb), and 161 unique genomic regions that encode 39 previously
unknown Map genes. Analysis of nucleotide substitution rates
with Mtb homologs suggest overall strong selection for a vast
majority of these shared mycobacterial genes, with only 68 ORFs
with a synonymous to nonsynonymous substitution ratio of >2.
Comparative sequence analysis reveals several noteworthy fea-
tures of the K-10 genome including: a relative paucity of the PEPPE
family of sequences that are implicated as virulence factors and
known to be immunostimulatory during Mtb infection; truncation
in the EntE domain of a salicyl-AMP ligase (MbtA), the first gene in
the mycobactin biosynthesis gene cluster, providing a possible
explanation for mycobactin dependence of Map; and Map-specific
sequences that are likely to serve as potential targets for sensitive
and specific molecular and immunologic diagnostic tests. Taken
together, the availability of the complete genome sequence offers
a foundation for the study of the genetic basis for virulence and
physiology in Map and enables the development of new genera-
tions of diagnostic tests for bovine Johne’s disease.
genomics  Johne’s disease  molecular diagnostics
Mycobacterium avium subspecies paratuberculosis (Map) isan extremely slow-growing, acid-fast, mycobactin-
dependent multispecies pathogen. Infection with this bacterium
leads to a chronic granulomatous enteritis in cattle and other
wild and domestic ruminants, termed Johne’s disease (1). Clin-
ical signs of Johne’s disease include diarrhea, weight loss,
decreased milk production, and mortality. A recent study esti-
mated that 21% of United States dairy herds are infected,
resulting in considerable economic losses to the dairy industry
totaling more than $200 million per annum (2, 3). A major
concern with Johne’s disease is the ease with which the bacte-
rium is spread. Subclinically or clinically infected animals shed
Map in feces and milk, enabling dissemination to susceptible
calves, the environment, and in retail milk (4–6). Map-
containing milk may be of particular concern because the
bacterium has been suggested as a possible cause of Crohn’s
disease in humans (7).
The detection and diagnosis of Map-infected animals poses
great difficulties. Map culture can require up to 16 weeks or
more, and serological tests lack sensitivity because of the sero-
conversion occurring relatively late during the course of the
disease (8). Also, previously developed PCR-based approaches
(e.g., IS900) have been shown to lack specificity (9). This result
is, in part, due to the high levels of genetic similarity of Map with
other mycobacteria, in particular, Mycobacterium avium (Mav)
(10). Previous studies from our laboratories and elsewhere show
95% nucleotide sequence similarity between many strains of
Map and Mav (11–13). Therefore, it is widely recognized that the
development of rapid, sensitive, and specific assays to identify
infected animals is essential to the formulation of rational
strategies to control the spread of Map.
As a first step toward elucidating the molecular basis of Map’s
physiology and virulence, and providing a foundation for the
development of the next generation of Map diagnostic tests and
vaccines, we report the complete genome sequence of a common
clone of Map, strain K-10.
Materials and Methods
Bacterial Strains. We chose to sequence Map K-10, a bovine
clinical isolate, because it is a virulent, low passage clinical strain
that was isolated from a dairy herd in Wisconsin by investigators
at the U.S. Department of Agriculture National Animal Disease
Center in the mid-1970s. In addition, K-10 is amenable to genetic
manipulation by transposon mutagenesis (14). The organism was
grown in Middlebrook 7H9 broth supplemented with OADC
(Difco), Tween 80, and mycobactin J (Allied Monitor, Fayette,
MO).
Sequence Analysis. A random shotgun approach was adopted to
sequence the genome of Map K-10 (15). To create a small (1.8-
to 3.0-kb) insert library, genomic DNA was initially isolated by
using a chloroformcetyltrimethylammonium bromide-based
method, as described (16). The DNA was sheared by nebuliza-
tion (www.genome.ou.edu) and 1.8- to 3.0-kb fragments were
cloned into pUC18 for isolation and sequencing. Approximately
30,240 clones and 3,000 PCR fragments were sequenced from
both ends via Dye-terminator chemistry on Applied Biosystems
3700 and 3100 sequencing machines. A total of 66,129 sequences
were used to generate the final assembly, representing a 6-fold
coverage of the genome. Sequence assembly was performed with
PHREDPHRAP (http:genome.washington.edu), and the 400
gaps that remained at the end of the shotgun phase were closed
by primer walking and multiplex random PCR.
Informatics. ORFs were predicted by both ARTEMIS and GLIMMER
and verified manually in ARTEMIS. BLASTP analysis of the ORFs
was performed at the Computational Biology Center at the
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University of Minnesota (www.cbc.umn.edu), and transfer
RNAs were predicted with TRNASCAN-SE (17–20). Comparative
genomic analysis was peformed with Mycobacterium tuberculosis
(Mtb), strain H37Rv (GenBank accession no. NC000962) and
Mav strain 104 (The Institute for Genomic Research, www.
tigr.org) (21, 22).
Results and Discussion
Characteristics of the Map Genome. The analysis showed that Map
K-10 has a single circular sequence of 4,829,781 base pairs, with
a GC content of 69.3% (Table 1 and Fig. 1). The putative origin
of replication was identified based on the presence of dnaA
boxes, characteristic oligomer skew, and G-C skew between the
putative genes dnaA and dnaN (18, 23). The initiation codon for
the dnaA gene was chosen as the start point for numbering the
genome (Fig. 1). The GC content is relatively constant
throughout the genome. The analysis also revealed only a few
genomic regions with lower GC content corresponding to
prophages or coding RNA sequences (Fig. 1).
As in the three other mycobacterial genomes sequenced to
date, Mtb, Mycobacterium leprae, and Mycobacterium bovis, a
single rrn operon (16S-23S-5S) was identified in K-10 along with
50 additional genes coding for functional RNA molecules. The
rrn operon is located 2.75 Mb from the putative oriC on the
opposite strand. This is 1.3 Mb further from the oriC than what
is described in Mtb (22).
Repetitive DNA in Map. Approximately 1.5% (or 72.2 kb) of the
Map genome is comprised of repetitive DNA like insertion
sequences, multigene families, and duplicated housekeeping
genes. The analysis also identified 17 copies of the previously
described insertion sequence IS900, seven copies of IS1311, and
three copies of ISMav2 in the K-10 genome (Fig. 2). A total of
16 additional Map insertion sequence elements were identified
in the analysis, totaling 19 different insertion sequences with 58
total copies in the K-10 genome. Although many of these newly
Table 1. Summary of the complete genome of M. paratuberculosis K-10 and the comparison with other
Mycobacterium species
Property Map Mav Mtb M. bovis M. leprae M. smegmatis
Genome size, bp 4,829,781 5,475,738 4,411,532 4,345,492 3,268,203 6,988,209
GC content, % 69.30 68.99 65.61 65.63 57.79 67.40
Protein coding, % 91.30 NA 90.80 90.59 49.50 92.42
ORFs 4,350 NA 3,959 3,953 1,604 6,897
Gene density, bp per gene 1,112 NA 1,114 1,099 2,037 1,013
Average gene length, bp 1,015 NA 1,012 995 1,011 936
tRNAs 45 45 45 45 45 47
rRNA operon 1 1 1 1 1 2
Fig. 1. Circular representation of the Map K-10 genome. From inside: red
arrow, rRNA operon; dark purple histogram, GC content; multicolored histo-
gram, MAP ORFs coded according to functional classification (small molecule
metabolism, blue; macromolecule metabolism, red; cell processes, purple; other
processes, yellow; hypotheticals, green; unknowns, orange). The outer colored
histogram indicates the same direction of transcription as the origin of replica-
tion. The inner colored histogram indicates the opposite direction of transcrip-
tion as the origin of replication. Black arrows, 45 tRNAs. Outer circle, scale. The
figure was generated with GENESCENE software (DNAstar, Madison, WI).
Fig. 2. Linear representation of repeat and unique regions within the Map
K-10 genome. From the top: Blue histogram, VNTRDR repeats; red histogram,
SSR repeats; green histogram, unique regions; multicolored histogram, inser-
tion sequences (IS900, blue; MAP01, aqua; MAP02, gray; MAP03, pink; MAP04,
green; MAP05, purple; MAP06, black, MAP07, orange; MAP08, red; MAP09,
light pink; MAP10, light purple; MAP11, beige; MAP12, brown;
MAP13,fuschia; MAP14, light aqua; MAP15, light gray; MAP 16, dark green;
IS1311, maroon; Mav2, light blue; REP, light green). Purple histogram, GC
content. The figure was generated with GENESCENE software (DNAstar,
Madison, WI).
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discovered Map IS elements are homologs with previously
described insertion sequences in Mtb, Mav, M. bovis, and Myco-
bacterium marinum, the analysis also revealed several insertion
sequences with no identifiable homologs in other mycobacteria.
For example, ISMAP02, present in six copies in the K-10
genome (Fig. 2), has no identified homolog in other mycobac-
teria and only very low levels of homology (28% identity) with
a transposase described in Legionella pneumophila. Similarly,
ISMAP04, present in four copies in the K-10 genome, has no
homologs in other mycobacteria but is similar to insertion
sequences found in Arthrobacter nicotinovorans and Streptomyces
coelicolor. These newly discovered IS elements are of particular
interest for their use as specific potential diagnostic targets due
to their absence in other mycobacteria. In addition, the analysis
identified 12 homologs to the REP13E12 family in K-10 (Fig. 2);
this is a 1,400-bp repeated insertion sequence that was first
described in the Mtb genome (24, 25).
It is believed that insertion sequences preferentially integrate
within intergenic regions so as to avoid the disruption of essential
genes (26). Consistent with this hypothesis, the majority of the
IS elements found in K-10 appear to be clustered within inter-
genic regions. For example, MAP0028c and MAP0029c,
MAP0849c and MAP0850c, and MAP2155, MAP2156, and
MAP2157 are clustered within 5 kb of each other in noncoding
regions of the chromosome (Fig. 2). The analysis also shows that
insertion sequences in Map are absent from the region flanking
32 kb of either side of the oriC. A similar observation was made
for the Mtb genome; however, in the case of Mtb, this distance
is considerably greater at 600 kb (24). It is thought that there may
be detrimental effects to chromosomal replication when inser-
tion sequences are located close to the oriC, thereby raising the
intriguing possibility that the presence of an insertion sequence,
(MAP0028cIS1311), 32 kb from the oriC in Map, may contrib-
ute to the increased generation interval of Map as compared with
Mtb and other mycobacteria (24).
Protein-Encoding Genes. The K-10 genome contains 4,350 ORFs
with lengths ranging from 114 bp (a ribosomal subunit encoding
gene) to 19,155 bp (a peptide synthetase), which, in sum, account
for 91.5% of the entire genome. A total of 52.5% of the genes
are transcribed with the same polarity as that of DNA replica-
tion, a fraction that is slightly lower than the 59% observed in
Mtb. Interestingly, there appears to be a higher bias toward
transcription in the same polarity as replication in some other
organisms (for e.g., 75% in Bacillus subtilis) (26, 27). Although
it is tempting to speculate that this bias may, in part, contribute
to the slow growth in Mtb and the even slower growth in Map,
it is important to note that only 55% of Escherichia coli genes are
transcribed in the same polarity as replication, suggesting that
gene location in relation to the origin of replication cannot fully
explain Map’s slow growth in laboratory culture (28).
The analysis showed that a total of 60% of the putative proteins
in Map had homologs to other microbial proteins with known
functions and 25% were homologous to hypothetical proteins
(Table 2 and Fig. 4, which are published as supporting information
on the PNAS web site). A total of 39 predicted proteins are unique
to Map, with no identifiable homologs in the current databases. Of
the predicted proteins, 75% had homology to those identified in
Mtb (22). Interestingly, the functional redundancy caused by gene
duplication that was previously observed in Mtb (52% of genes are
functionally redundant) exists to an even greater extent in Map (29).
Functional redundancy, based on amino acid homology compari-
sons, is particularly high among genes involved in lipid metabolism
and oxidoreduction; for instance, there are 254 predicted genes
functioning as oxidoreductases and oxygenases, compared to 171 in
Mtb.
The Map genome encodes the complete set of enzymes for
many metabolic pathways including glycolysis, the pentose phos-
phate pathway, the tricarboxylic acid cycle, and the glyoxylate
cycle. However, there are genes and putative pathways missing
in the Map genome that have been described in Mtb. For
example, Mtb encodes the necessary genes for urease production
(ureABC and ureDFG). Bacterial ureases catalyze the hydrolysis
of urea to ammonia and carbon dioxide. The ability to acquire
nitrogen from urea is important in the colonization of varying
environments, including a host (30). Because Map lacks this
specific pathway (ureABC and ureDFG), its ability to acquire
nitrogen from urea may differ from that of Mtb and other
urease-producing bacteria.
It is not surprising that the analysis shows a large number (n 
150) of genes with regulatory functions in the Map genome
(Table 2 and Fig. 4). This number is greater than what is found
in Mtb (n  100) and is consistent with the ability of Map to
survive in a wide range of environmental conditions (22). The
analysis identified 14 complete two-component systems in Map
as compared with the 11 described in Mtb. This finding is in stark
contrast to what is seen in B. subtilis and E. coli, where 30
copies have been described (27, 28). It is believed that the low
number of two-component systems is offset in Mtb by the
presence of serinethreonine protein kinases (STPKs), which
are part of the phosphorelay system (31); this may be true in Map
as well, because our analysis identified a total of 16 genes with
a potential role STPK biosynthesis.
Evolutionary Relationships of Map. To understand the level and
nature of nucleotide variation between Map and Mtb, amino acid
substitution rates for the aligned gene sequences were calculated
based on the algorithm of Nei and Gojobori (32). For genes with
critical roles in bacterial survival and fitness, the rate of non-
synonymous substitution (dN) is often lower than the rate of
synonymous substitution (dS) because these genes are under
functional constraint and the majority of phenotypic changes will
be disadvantageous. In comparison to Mtb, the majority of Map
dN:dS ratios fall in the range of 1:10 to 1:4, corresponding to the
most highly conserved sequences (Table 3, which is published as
supporting information on the PNAS web site). The low average
ratio of dN:dS for Map compared to Mtb indicates that the
majority of Map genes are under functional constraint (Fig. 5,
which is published as supporting information on the PNAS web
site). The analysis also identified 63 orthologs with dNdS ratios
2, indicating that substitutions that result in a change in the
primary structure of the proteins are overrepresented at these
loci. Of particular interest is a gene (MAP0638) with the highest
dNdS ratio of 7.3 that has homology to an amidophosphoribo-
syltransferase (ATase). This gene is primarily responsible for
regulation and production of purine synthesis and has also been
shown to play a role in the rate of DNA and protein synthesis and
cell growth (33). It is tempting to speculate that the increased
level of substitution in this gene may play a role in a decreased
growth rate in Map in comparison to Mtb, a hypothesis that
remains to be tested. Although most of the putative protein
products from these highly substituted genes were hypothetical,
other genes of interest included several transcriptional regula-
tors and 11 genes that play a putative role as cell envelope
proteins (Table 4, which is published as supporting information
on the PNAS web site).
Mycobactin Synthesis. One major phenotypic difference between
Map and other mycobacteria is its inability to produce myco-
bactin in laboratory culture. Mycobactin is a siderophore that is
responsible for the binding or transport of iron into cells.
Because of the importance of iron in electron transport and as
a key component of various metabolic enzymes, it is essential
that bacteria have the ability to acquire iron from various
sources. A cluster of 10 genes in Mtb (mbtA–J) has been shown
to be responsible for the production of mycobactin and the
12346  www.pnas.orgcgidoi10.1073pnas.0505662102 Li et al.
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transport of iron (34). Homologs to the mbtA–J cluster were
identified in the Map genome. However, a direct comparison of
the MbtA–J cluster in Map with those of Mav and Mtb show
significant differences in primary structure of this region (Fig. 3
and Table 5, which is published as supporting information on the
PNAS web site). First, in Mtb, mbtI (trpE2) and mbtJ (lipK) are
adjacent to each other and immediately downstream of the
mycobactin biosynthesis gene cluster (Fig. 3) (34). However, in
Map and Mav, there is a 6.6- and 5.7-kb gap, respectively,
between the two genes. Furthermore, there is 19.3-kb gap in Map
and 197.3-kb gap in Mav between mbtJ and mbtA of mbt cluster,
confirming a preliminary observation made by DNA microarray
analysis (35). Because Mav can successfully produce mycobactin,
the distance in genes is not likely to be the limiting factor that
affects the production of mycobactin in Map. Second, we iden-
tified frame-shift mutations in both mbtB and mbtE in Map when
compared with Mtb. The mbtB frameshift also appears in Mav,
suggesting that this too is not the limiting factor affecting
mycobactin production in Map (Fig. 3). In addition, even though
the gene is divided, all functional domains identified in Mtb
appear to be present in the mbtB gene product in Map, suggesting
that its function could still be maintained. A similar frameshift
exists in the mbtE gene in Map as well, but the functional
domains of MbtE that are present in Mtb are present in Map as
well. For each of mbtC, mbtD, and mbtF, the gene products
include the common domains that are found in corresponding
proteins in Mtb.
The major difference between Map, Mav, and Mtb in the
mbtA-J cluster was in the mbtA gene. Gene mbtA is shorter in
Map: encoding a 400-aa protein, compared with 565- and
551-residue polypeptides in Mtb and Mav, respectively. As a
result of this truncation, MbtA has only 337 residues in Map with
homology to the N-terminal of the EntE domain, and lacks 200
residues of the EntE C terminus that are presumably important
for protein function. Because MbtA is thought to initiate my-
cobactin production, the truncation observed in this key gene
suggests that the entire cascade leading to mycobactin produc-
tion may be attenuated in Map (34). Therefore, it is tempting to
speculate that the truncated EntE domain in the mbtA gene
product in Map might be the limiting factor in mycobactin
production, a hypothesis that remains to be formally tested.
Immunological and Virulence-Related Insights from the Map Genome.
Despite intensive research efforts, there is still little information
regarding the molecular basis for Map pathogenesis. Hence, we
paid particular attention to the identification of genes with a
potential role in pathogenesis in the Map genome and note
several interesting observations. There is a paucity in the number
of the PEPPE family of proteins that are thought to play an
important role in mycobacterial infection from both an antigenic
as well as an immunologic standpoint. These proteins are acidic
and glycine-rich proteins, and are identified by their specific
domains (Pro-Pro-Glu and Pro-Glu, respectively) that fre-
quently contain polymorphic repetitive sequences (PGRSs) and
multiple copies of major polymorphic tandem repeats, respec-
tively (22, 36–39). These proteins are thought to be expressed on
the cell surface and provide the antigenic variation that elicits
varying immunological responses in Mtb depending on the type
of PEPPE protein expressed on the cell surface (22, 40).
Genome-scale comparisons between two isolates of Mtb show
that regions of the genome encoding PEPPE proteins have a
higher single-base substitution frequency, further supporting the
hypothesis that they are recognized by the immune system and
hence subject to positive Darwinian selection (40). Although
these families of proteins comprise 10% of the Mtb genome,
there were only six PE homologs and 36 PPE homologs in Map
(comprising 1% of the genome) compared to 38 and 68, respec-
tively, in Mtb (22). Within the PE family, there is no intact
PE-PGRS subfamily of proteins identified in the K-10 genome,
although this subfamily has been identified in other mycobac-
teria including M. bovis and M. marinum (41). Interestingly, this
subfamily of proteins is also absent in Mav and M. leprae (42).
Although the exact significance of this observation is unknown,
it may suggest a more limited, less variable, and different
immune response toward Map as compared with Mtb. This
observation also leads to the tempting speculation that antimi-
crobial agents and vaccines directed against these major viru-
lence factors may be more likely to be effective against Map as
compared with Mtb.
Pathogens often express proteins that alter the effects of the
host’s immune response so as to evade destruction. Because
mycobacteria are facultative pathogens and are assumed to
selectively express specific genes to allow for survival inside the
host macrophage, much attention has been directed toward the
characterization of virulence genes that are important for
the entry and persistence in the host (43). One such gene, the
mammalian cell entry (mce) gene, has been identified in Mtb (44)
and was shown to enhance E. coli’s ability to survive in macro-
phages (44). Four copies of the mce gene are present in Mtb (22).
The analysis of the complete sequence of the Map genome
revealed eight homologs of the mce gene. The gene has also been
identified in different mycobacterial species, including Mav,
M. bovis, and Mycobacterium smegmatis. The wide distribution of
the mce operons in pathogenic and nonpathogenic mycobacteria
implies that the mere presence of these genes does not endow a
bacterium with the ability to cause disease. However, the role of
this operon in virulence may be determined by its expression
under specific conditions (43, 45, 46).
Fig. 3. Homology comparison of the mycobactin gene cluster between Map K-10, Mav 104, and Mtb H37Rv. The gene cluster is shown in gray with amino acid
length indicated above each box. Gene names are indicated.
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Mycobacteria were originally classified as such by the presence
of mycolic acids (47, 48). Not only do mycobacteria produce this
type of lipid, but these organisms are also known for their ability
to produce and use a vast array of other lipophilic molecules (47).
Importantly, these diverse structures that are located primarily
on the cell wall are thought to play a role in pathogenesis in many
mycobacterial species by their ability to allow entry into host cells
or suppress or evade host immune defense mechanisms (49, 50).
Increased survival of mycobacteria may also be enabled, in part,
by their ability to preferentially use fatty acids instead of
carbohydrates for basic metabolic needs (51–53). Our analysis
shows that there are 80 more genes in Map (n  266) that are
predicted to be involved in lipid metabolism than there are in
Mtb. Although this difference in number of lipid metabolism and
biosynthesis related genes is due primarily to genetic redundancy
in Map, there are some noteworthy differences. For example,
Map contains a gene (MAP3194) encoding hydroxymethylglu-
taryl–CoA lyase, an enzyme that is found in other bacteria as well
as in humans, and catalyzes the last step of ketogenesis and
leucine catabolism (54). The enzyme may play a role in fatty acid
biosynthesis by altering what is produced and distributed to the
cell membrane (54). This difference between Map and Mtb
indicates there may be variation in lipid metabolism and bio-
synthesis that may play a role in antigens presentabsent on the
cell surface, thus, affecting host immune defense mechanisms.
Map lacks one of the largest operons in Mtb involved in the
production of phenolpthiocerol, a polyketide. In the Mtb ge-
nome, this operon (ppsABCDE) is immediately upstream of
another gene cluster (mas), which encodes an enzyme respon-
sible for the synthesis of mycocerosic acid. In combination, these
two products form the abundant cell-wall-associated molecule
phthiocerol dimycocerosate (DIM) (22). Importantly, it has been
found that Mtb isolates lacking this cell wall lipid are attenuated
in virulence (55–57). Map contains no homologs to either the
ppsABCDE or the mas gene homologs. Instead, the analysis
identified 35 other genes with a possible role in polyketide
synthesis (including 12 involved in mycobactin biosynthesis;
Table 2). Included among these are chalcone synthase-like
genes. These polyketides are found primarily in plants, but a
four-gene cluster (pks7-10) has been identified in Mtb with high
similarity to a chalcone synthase-like genes (22). Similarly, a
four-gene cluster was identified in Map (MAP1369, MAP1370,
MAP1371, and MAP1372). These polyketides are believed to be
involved in the production of DIM in Mtb as well as in its
virulence (57). Mutations in pks10 showed attenuation of the
virulent Mtb H37Rv isolate upon infection of alveolar macro-
phages (57). Therefore, although Map lacks the two major gene
clusters required for the production of the polyketide DIM in
Mtb, the analysis identified other genes that may play a role in
DIM and polyketide synthesis in Map. These results suggest that
there are likely to be considerable differences in the presence or
expression of various lipids on the cell surface of Map that may
in turn have a major influence on the virulence and host
specificity of this bacterium. In addition, the relative lack of
functional redundancy in this pathway in Map suggests that the
inactivation of the putative DIM polyketide biosynthesis path-
way related genes in Map may be a promising approach to the
development of attenuated or vaccine strains in this organism.
Map Diagnostics and Strain Differentiation. The identification of
unique sequences within the Map genome has already provided a
foundation on which to design and implement better diagnostic
assays for Map detection. Our analysis has identified 161 unique
sequence regions in the Map genome, with the longest region being
15.9 kb in length (Fig. 1). More importantly, our preliminary studies
show that these unique sequences have considerable potential for
the development of more specific and sensitive diagnostic assays for
detection of Map infection with both molecular and immunoassay
based approaches (58–61). Our more recent studies, enabled by the
identification of the unique regions in the Map genome, have
resulted in the development of highly sensitive real-time PCR-based
approaches for the sensitive and specific detection of Map directly
from bovine feces (N.B., L.L., A.A., J.P.B., V.K., and S.K., unpub-
lished data). Studies are also underway to heterologously express
unique Map genes as well as the genes encoding cell surface
proteins for construction of a partial protein array to evaluate the
humoral and cell-mediated immunostimulatory capabilities of these
recently discovered unique proteins. Therefore, the combination of
genomic information, molecular tools, and immunological assays
will provide key insights to the host immune response to Map
infection. Overall, the elucidation of all of the unique sequences as
well as those that may be associated with the cell surface of Map
provides a strong foundation on which to develop the next gener-
ation of specific and sensitive diagnostic assays for Map.
Short sequence repeats (SSRs) or variable number tandem
repeat (VNTR) sequences have been used as markers for
differentiation and subtyping strains of several bacterial spe-
cies including Mtb, Yersinia pestis, and Bacillus anthracis
(62–65). SSRs consist of simple homopolymeric tracts of single
nucleotide (mononucleotide repeat) or multimeric tracts (of
homogeneous or heterogeneous repeat), such as di- or trinu-
cleotide repeats, which can be identified as VNTRs in the
genome of the organism (66). The variability of the repeats is
believed to be caused by slipped-strand mispairing, the genetic
instability of polynucleotide tracts, especially poly(G-T), and
DNA recombination between homologous repeat sequences.
In preliminary bioinformatic analyses, we had identified 185
mono-, di-, and trinucleotide repeat sequences dispersed
throughout the Map genome, of which 78 were perfect repeats
(67). Comparative nucleotide sequencing of the 78 loci in six
Map isolates from different host species and geographic
locations identified a subset of 11 polymorphic SSRs with an
average of 3.2 alleles per locus (67), and has provided the
foundation for the development of highly discriminatory and
powerful multilocus SSR (MLSSR)-based typing approach for
strain differentiation among isolates of Map (68). In the
current investigation, we identified an additional 362 se-
quences representing either direct or indirect sequence repeats
of length distribution of 6–74 bp with a repeat number ranging
from 2 to 16, and with a mutual homology of 67–100% (Fig.
2). Based on our recent success using MLSSR for Map strain
differentiation and in understanding the molecular epidemi-
ology of the organism, it is likely that these repeat elements in
the Map genome will provide additional strain differentiation
capabilities and may enable rapid and facile discrimination of
epidemiologically and geographically distinct strains of isolates
of Map by using nonsequencing based approaches as well (69).
It is noteworthy that the availability of the full complement of
all of the genes in Map provides an opportunity to perform a
complete metabolic reconstruction to enable a better under-
standing of the natural physiology of this organism and the
metabolic requirements for growth, and thereby enable faster
growth of Map in laboratory culture.
Concluding Comments. In summary, the complete genome se-
quencing and comparative genomics analyses described herein
have provided key insights and a strong foundation for future
investigations on the genetics, evolution, natural physiology, and
virulence of this important animal pathogen. Furthermore, the
results of our studies provide the foundation for the development
of the next generation of diagnostic and strain differentiation
approaches, and provide a framework for the application of
genomics and proteomics based approaches for the development
of vaccines to prevent and control Johne’s disease in domestic
livestock.
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